https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/046cd43c-ade8-4bac-a08b-6304150375a8/23-2023-american-college-of-rheumatology-acr-american-colleg 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/04d513cc-dc39-4b1f-8800-be502ffc17f9/cd-20 2026-01-30T15:21:29Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/07c3e3b8-34ff-4bc2-b2c5-1e26ee6226d9/deucravacitinib 2026-02-04T16:36:06Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/08b25631-e31e-4722-ae23-78750dab0499/25-real-world-experience-of-anifrolumab-in-30-patients-withr 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/09a42e8e-4088-4039-b0dd-e456e9a70e11/t-cell-therapies 2026-01-30T15:50:14Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/09b78fc1-a2dc-4e6e-b9da-2926dfc4931a/cd38-plasmablasts-and-cells 2026-01-30T15:22:41Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/10c311f6-b791-4c27-93e8-9363454d1c6e/21-study-of-tofacitinib-in-refractory-dermatomyositis-stir 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/15c3f353-f022-43a0-9e25-dcb6554c9e38/ild 2026-07-12T19:20:46Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/1621c747-b67e-4f10-8275-6b03033d9c80/22-ef-cacy-of-intravenous-immunoglobulins-ivig-in-improvings 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/1b304e67-e21f-4869-bb52-f1de79128c47/compare-by-cdasi 2026-02-02T15:22:06Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/22d53dcc-c842-4e88-928d-0f5aafcbb207/haq 2026-01-31T17:50:08Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/270f8228-d9d0-47cf-ad3c-089ea7f7f06e/daratumumab 2026-01-30T16:25:33Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/27837619-fd8e-4a9f-b876-8ad53f7838dc/25-dazukibart 2026-02-01T17:18:34Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/28a0c9c2-14bb-4b43-93ae-a790db2fbb28/ivig 2026-01-31T16:04:37Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/318bcd2d-f591-443a-b7ce-4990e2de236c/22-nintedanib-in-patients-with-autoimmune-disease-related-pr 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/3556c407-4de3-43d8-9ec0-0f4b319f8b45/tofa-bari-upada-ruxoli 2026-03-20T22:15:08Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/378a7fd5-2f90-4c15-9f56-aa2dc291bfd1/clinical-outcomes 2026-02-02T18:49:10Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/454d1918-7cae-458a-b45e-d435df85f841/23-rituximab-versus-intravenous-cyclophosphamide-in-patients 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/468e2194-eac9-4d25-918e-ab9fb76ad2fb/23-analysis-rituximab-compared-to-intravenous-cyclophosphami 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/5775916b-741c-4ee5-9baf-e028eac30b05/25-experience-on-the-use-of-obinutuzumab-o-label-in-patients 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/57955f1d-4de3-4004-bb65-2abcccaa8ca2/ild-in-ctd 2026-02-02T18:44:51Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/5a644ed5-213b-40e0-9c0c-302b9ec2b1a5/myositis-antibodies-treatment 2026-03-18T13:57:20Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/5b5c657a-d94b-4c2d-b3a1-4a25fdb7a3c0/25-upadacitinib-therapy-in-refractoryinflammatory-myositis 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/602fe0e6-8dab-466d-a398-fb26624365c3/sirolimus 2026-01-30T15:46:33Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/62be8c93-1b6e-4897-8ee5-bc9fa4ec1a9a/comparison-for-ild 2026-02-02T18:38:56Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/636e008e-12bc-47b1-b7ec-54dcf1b99476/other-early-trials 2026-02-04T16:22:01Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/67612c90-2fb3-4fb5-aa16-c123cb5f55a8/23-rescue-combination-treatment-of-anti-mda5-associated-ards 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/6784c411-9bfe-4e72-97b4-10b0c21061d1/obinutuzumab 2026-02-01T17:47:47Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/72bfd808-6729-4fa3-a162-a9c48803635f/evaluation-instruments 2026-01-31T16:56:46Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/72e6c33e-32fa-4d1f-a7bf-bf872012346b/failed 2026-01-30T15:43:36Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/7514fb15-0995-4b15-968a-8441da1b5fdb/md-haq 2026-01-31T18:03:24Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/7a9ebdff-162e-4ac3-a2c1-9d33c083044b/articles 2026-03-06T22:52:38Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/7aabe905-3b8d-4359-b476-aeea3e011afe/24-baricitinib-in-the-treatment-of-adult-idiopathic-inflamma 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/81e80e8d-7e09-4566-8e1b-94037ba4deec/resecel 2026-01-30T16:07:18Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/890c52d1-688d-401f-8194-9db3701400b3/cni-m-tor 2026-01-30T15:46:21Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/8ca86ba9-5547-474c-9eac-40692a5829f6/imacs 2026-02-06T14:09:25Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/8e025196-647e-4316-a20e-3b800e45cd29/comparisons 2026-02-01T18:28:30Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/91b87718-f2ec-44d0-87d9-b800d95d54b1/cdasi-a 2026-02-05T14:08:01Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/9442c58b-2c45-4dc5-89f3-8cc45452c61a/ild 2026-02-02T18:45:25Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/97613b4b-d668-4efa-9604-1957ba2d7e8a/19-long-term-treatment-with-azathioprine-and-mycophenolate-m 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/97a4137c-ad9f-464d-9184-59c2cffed488/jak-tyk-i 2026-03-20T22:04:13Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/99494ef1-1dfb-40de-83fa-9c6c0b15fddf/tacrolimus 2026-03-20T22:12:14Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/9f6adc21-d2b9-48ad-9b00-351e708c1b7f/22-trial-of-intravenous-immune-globulinin-dermatomyositis 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/a09be05d-944b-4944-86e5-b01a540ebb8b/compare-by-tis 2026-02-01T18:25:31Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/a128523e-5d2b-4594-8758-7dc74b02d85d/25-treatment-guidelines-for-idiopathic-inflammatorymyopathie 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/ae985cda-6a1e-4e23-995c-2011ab3ba2b2/ifn 2026-01-31T16:20:39Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/b06cbef1-dff9-4124-88cc-f67223249c8e/efgartigimod-ph20-sc-fcrn-inhibitor 2026-02-04T16:38:49Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/b07fc9a2-a702-4150-8123-c20af0143fbd/rituximab 2026-01-30T15:25:38Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/b27c59fd-64da-4800-a028-4559041de511/il-6 2026-02-01T17:37:24Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/b45e3849-57be-4f93-8174-3dfa3f649f13/anifro-dazuk-comparison 2026-01-31T16:53:09Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/b94ab3af-c39e-4511-9bb4-02f42db1287f/eculizumab 2026-01-30T16:20:20Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/c5853258-7c87-4b16-920e-6ab5a123695e/il-6r-tocilizumab 2026-01-30T15:18:52Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/c7b5db14-6d28-4d84-8184-e1f167aad28f/22-british-society-for-rheumatology-guideline-onmanagement-o 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/c7d3a4bf-6853-4c79-90b8-c3b12b259af6/ravulizumab 2026-02-04T16:47:10Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/d01ed899-b7a1-4f33-85a0-4bd5faa0b9f1/iim-treatment-perspectives 2026-07-12T19:20:46Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/d30210e6-6582-46a1-abee-e45f3cd023fa/cpk-or-strength 2026-03-18T14:00:04Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/d32d711d-3b2f-4b48-a7a0-5d295a6ed7e4/arimoclomol 2026-01-30T15:45:13Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/d45029f8-47a0-472f-bc4f-4ffb07dd7b1d/brepocitinib 2026-03-20T22:10:50Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/d4d3df4a-8d3c-4963-8ae7-20b07eea8ba0/25-efficacy-of-intravenous-immunoglobulin-for-systemic-manif 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/d4e1fe85-179b-4153-90cf-97c3aecb318e/tis 2026-01-31T17:47:35Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/dcf9533c-1315-4266-ac39-17cd4613de98/tofa-in-iim-for-ild 2026-01-30T16:40:34Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/dd0ae477-e082-413a-8b3f-57bec979a9e3/belimumab 2026-01-30T15:44:31Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/e1e04b1e-92e8-4812-b270-ce0f5b32ebb9/dazukibart-ifn-beta 2026-01-31T16:21:36Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/e2327471-40e2-4fad-b77f-6c82cc7f0efe/anifrolumab-ifnar1 2026-01-31T16:54:31Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/e2a4e857-bb5f-4e55-aa68-10de5c4aa685/complement 2026-01-30T15:23:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/e30f3d9c-8014-4093-ba48-c7a0e0d1a451/baff 2026-01-30T15:14:19Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/f3a0583a-a8b5-4ff0-bedd-25b802603b3e/c5 2026-01-30T15:23:44Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/f3a2e45f-f556-408c-a560-9cd2414c2582/25-valor-positive-phase-3-study-results-for-brepocitinib 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/f4ed8aaa-a6e4-4d8c-9a92-7b5e8ab0bb36/22-rituximab-in-the-treatment-of-refractory-adult-and-juveni 2026-04-02T22:14:32Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/f9824f8e-aa30-4d64-97ef-f8e43ba38304/mmt-8 2026-01-31T17:45:51Z https://app.thebrain.com/preview/c8fb42e5-a948-44b9-9567-43b63bbd4e45/feba488f-73a0-4452-90be-c1162a05def6/22-the-efficacy-of-tocilizumab-in-the-treatment-of-patients 2026-04-02T22:14:32Z